ConvaTec Group PLC (CNVVF)
OTCMKTS · Delayed Price · Currency is USD
3.478
0.00 (0.00%)
At close: Jul 14, 2025

ConvaTec Group Company Description

ConvaTec Group PLC engages in the development, manufacturing, and sale of medical products, services and technologies in Europe, North America, and internationally.

The company offers advanced wound care products for the management of acute and chronic wounds resulting from various conditions, such as diabetes, and acute conditions resulting from traumatic injury and burns.

It also provides ostomy care solutions, including devices, accessories, and services for people with a stoma resulting from colorectal cancer, bladder cancer, inflammatory bowel disease, and trauma.

In addition, the company offers continence care products and services for people with urinary continence issues related to spinal cord injuries, neurological disease, prostate enlargement or other causes.

Further, it provides infusion care solutions comprising disposable infusion sets for diabetes insulin pumps, or for used in continuous infusion treatments for conditions such as Parkinson’s disease.

The company sells its products to pharmacies, hospitals, and other acute and post-acute healthcare service providers directly or through distributors and wholesalers.

It serves a range of customers, including healthcare providers, patients, and manufacturers. ConvaTec Group PLC was founded in 1978 and is headquartered in London, the United Kingdom.

ConvaTec Group PLC
ConvaTec Group logo
CountryUnited Kingdom
Founded1978
IndustryMedical Instruments & Supplies
SectorHealthcare
Employees10,489
CEOKarim Bitar

Contact Details

Address:
20 Eastbourne Terrace
London, W2 6LG
United Kingdom
Websiteconvatecgroup.com

Stock Details

Ticker SymbolCNVVF
ExchangeOTCMKTS
Stock TypeCommon Stock
Fiscal YearJanuary - December
Reporting CurrencyUSD
ISIN NumberGB00BD3VFW73
SIC Code3842

Key Executives

NamePosition
Karim BitarChief Executive Officer and Director
Jonathan Peter MasonGroup Chief Financial Officer and Director
John HallerExecutive Vice President and Chief Quality and Operations Officer
Dr. Divakar Ramakrishnan Ph.D.Executive Vice President, Chief Technology Officer and Head of Research and Development
James Edward Spencer KertonEVice President, General Counsel and Company Secretary
Emma RoseExecutive Vice President and Chief People Officer
Kjersti Grimsrud Biotechnology, M.Sc.President and Chief Operating Officer of Infusion Care
David ShepherdPresident and Chief Operating Officer of Global Advanced Wound Care
Seth R. SegelPresident and Chief Operating Officer of Continence Care and Home Services Group
Evelyn Douglas J.D.Executive Vice President and Chief Strategy and Business Development Officer